| Literature DB >> 32256161 |
Carla Leal1, Rafaela A Santos1, Rosa Pinto1, Marcelo Queiroz1, Miguel Rodrigues1, Maria José Saavedra1, Ana Barros1, Irene Gouvinhas1.
Abstract
The grape is a matrix rich in bioactive compounds and its production generates large quantities of by-products, such as grape stems, which, to date, present low commercial value. However, there is a growing interest in the application of this material as a source of phenolic compounds. Therefore, the present study aims at assessing the phytochemical profile of (poly)phenolic extracts of white Portuguese grape stem varieties produced in the Região Demarcada do Douro (Portugal). The antioxidant activity determined by several assays, as well as the antimicrobial activity using the disc diffusion method against human gastrointestinal pathogenic bacteria of the hydromethanolic extracts, were evaluated. This work presents very positive results as the rich composition in phenolic compounds (94.71-123.09 mg GA-1 and 0.02-73.79 mg g-1 for the total phenol content and for individual phenolics, respectively) presented by grape stems can explain the high antioxidant (0.37-1.17 mmol Trolox g-1) and antimicrobial activities against, essentially, Gram-positive bacteria, and in some cases with higher efficacy than commercial antibiotics. Thus, demonstrating that this wine by-product should deserve greater attention from the pharmaceutical industries due to its excellent biological properties and characteristics not yet applied.Entities:
Keywords: Antimicrobial activity; Antioxidant activity; Grape stems; Pathogenic bacteria; Phenolic compounds
Year: 2020 PMID: 32256161 PMCID: PMC7105666 DOI: 10.1016/j.sjbs.2020.02.013
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 1319-562X Impact factor: 4.219
Bacterial isolates tested.
| Bacterial isolates | Source | Class |
|---|---|---|
| American Type Culture Collection | Gram + | |
| Clinical-human gastrointestinal segment | Gram + | |
| Clinical-human gastrointestinal segment | Gram + | |
| American Type Culture Collection | Gram - | |
| Clinical-human gastrointestinal segment | Gram - | |
| Clinical-human gastrointestinal segment | Gram - |
Phenolic content of grape stem extracts.
| Samples | Total phenols (mg GA g −1 dw) | Flavonoids (mg CAT g −1 dw) | |
|---|---|---|---|
| Rabigato | 82,12 ± 5,48a | 86,22 ± 5,42b | |
| Malvasia Fina | 123,09 ± 5,02b | 116,18 ± 2,67c | 106,42 ± 4,63c |
| Fernão Pires | 110,15 ± 8,47ab | 91,55 ± 7,04ab | 51,37 ± 2,39a |
| Viosinho | 96,99 ± 4,53a | 80,62 ± 3,69a | 61,75 ± 3,94a |
| Moscatel | 108,71 ± 9,41ab | 99,38 ± 8,13b | 59,43 ± 3,17a |
| *** | *** |
Values are presented as mean ± standard deviation (n = 3). Different letters indicate significantly different results (ANOVA, p < 0.05).
Significance: non-significant, N.S. (p > 0.05); * significant at p < 0.05; ** significant at p < 0.01; *** significant at p < 0.001.
Fig. 1Representative RP-HPLC-DAD chromatogram of white grape stems and identified compounds at 330 nm corresponding to the variety 'Moscatel'.
Phenolic compounds present in grape stem extracts.
| Phenolic compounds | Rabigato (mg g −1 dw) | Malvasia Fina (mg g −1dw) | Fernão Pires (mg g −1 dw) | Viosinho (mg g −1 dw) | Moscatel (mg g −1 dw) | |
|---|---|---|---|---|---|---|
Isohamnetin-3- | 0,60 ± 0,00a | 0,57 ± 0,04a | 0,60 ± 0,00a | 0,60 ± 0,02a | ||
Caftaric acid | 2,28 ± 0,05b | 12,82 ± 0,15d | 1,71 ± 0,02a | 1,51 ± 0,04a | 5,01 ± 0,19c | *** |
Unidentified hydroxycinnamic acid | 0,59 ± 0,04a | 3,36 ± 0,09c | 0,45 ± 0,01a | 0,63 ± 0,11a | 2,58 ± 0,09b | *** |
Q-3- | 0,15 ± 0,01bc | 0,19 ± 0,01c | 0,14 ± 0,01b | 0,05 ± 0,00a | 0,23 ± 0,02d | *** |
Q-3- | 37,56 ± 2,09ab | 73,79 ± 0,79c | 40,27 ± 0,04b | 34,63 ± 4,72ab | 29,27 ± 1,39a | *** |
K-3- | 0,04 ± 0,00a | 0,40 ± 0,02c | 0,14 ± 0,01b | 0,10 ± 0,01b | 0,14 ± 0,01b | *** |
K-3- | 0,02 ± 0,01a | 0,02 ± 0,01a | 0,04 ± 0,00a | 0,04 ± 0,01a | 0,04 ± 0,01a | N. S. |
Ɛ-viniferin | 0,31 ± 0,01a | 0,17 ± 0,00a | 0,90 ± 0,03b | 0,83 ± 0,15b | 0,76 ± 0,05b | *** |
Glc, glucoside; Gluc, glucuronide; K, kaempferol; Q, quercetin; Rut, rutinoside.
The values are presented as mean ± standard deviation (n = 3). Different letters indicate significantly different results (ANOVA, p < 0.05).
Significance: non-significant, N.S. (p > 0.05); * significant at p < 0.05; ** significant at p < 0.01; *** significant at p < 0.001.
Fig. 2Antioxidant activity of grape stem extracts by ABTS and DPPH methods. Columns with different letters indicate significantly different results (ANOVA, p < 0.05).
% RIZD relative to antibiotics tested.
| Antibiotics | CN10 | CN30 | CIP10 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bacterial isolates | RG | MF | FP | VS | MP | RG | MF | FP | VS | MP | RG | MF | FP | VS | MP | |||
| 51b | 44a | 47ab | 49ab | * | 44a | 47a | 40a | 44a | 45a | N.S. | 44ab | 47b | 40a | 44ab | 45ab | |||
| # | # | # | # | # | – | # | # | # | # | # | – | # | # | # | # | # | – | |
| # | # | # | # | # | – | # | # | # | # | # | – | # | # | # | # | # | – | |
| 100ab | 110b | 100ab | 93a | 100ab | * | 78ab | 87b | 78ab | 73a | 78ab | N.S. | 48a | 53a | 48a | 45a | 48a | N. S. | |
| 0 | 0 | 0 | 0 | 0 | – | 0 | 0 | 0 | 0 | 0 | – | 0 | 0 | 0 | 0 | 0 | – | |
| 0 | 0 | 0 | 0 | 0 | – | 0 | 0 | 0 | 0 | 0 | – | 0 | 0 | 0 | 0 | 0 | – | |
CN10: Gentamicin (10 µg per disc); CN30: Gentamicin (30 µg per disc); CIP10: Ciprofloxacin (10 µg per disc); RG: Rabigato; MF: Malvasia Fina; VS: Viosinho; FP: Fernão Pires; MP: Moscatel.
# Extract effective and antibiotic without effect.
Values in the same row for each clinical antibiotic followed by different superscript lowercase letters are significantly different at p < 0.05.
Significance: non-significant, N.S. (p > 0.05); * significant at p < 0.05; ** significant at p < 0.01; *** significant at p < 0.001.
Antimicrobial classification of the tested grape stem extracts.
| Antibiotics | CN10 | CN30 | CIP10 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bacterial isolates | RG | MF | VS | FP | MP | RG | MF | VS | FP | MP | RG | MF | VS | FP | MP |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | |
| +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | |
| +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | |
| + | ++ | + | + | + | + | + | + | + | + | + | + | + | + | + | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
CN10: Gentamicin (10 µg per disc); CN30: Gentamicin (30 µg per disc); CIP10: Ciprofloxacin (10 µg per disc); RG: Rabigato; MF: Malvasia Fina; VS: Viosinho; FP: Fernão Pires; MP: Moscatel; no effect: -; moderate efficacy: +; good efficacy: ++; high efficacy: +++.